<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>POLY HIST CB- carbetapentane citrate and guaifenesin liquid </strong><br>Poly Pharmaceuticals, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Poly Hist CB</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>POLY HIST CB</h1>Antitussive/Expectorant<br>Rx Only<br><br>Description: POLY HIST CB is an alcohol-free, sugar-free, purple liquid for oral administration <br>having a grape odor and flavor.<br><span class="Bold"><br>Each Teaspoon (5 mL) Contains:</span><br>CARBETAPENTANE CITRATE............................ 20 mg<br>GUAIFENESIN ....................................................75 mg<br><br>POLY HIST CB Liquid also contains: FD and C Blue #1, FD and C Red #40, Grape Flavor, Maltitol, <br>Propylene Glycol, Sodium Saccharin, Sorbitol, Purified Water.<br>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>Clinical Pharmacology:</h1>Carbetapentane citrate is a centrally acting non-narcotic antitussive.<br><br>Guaifenesin is an expectorant. Its action increases the output of respiratory tract fluid by reducing <br>adhesiveness and surface <span class="product-label-link" type="condition" conceptid="4200706" conceptname="Tension">tension</span>. Sinus and bronchial drainage is improved and dry, nonproductive <br><span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">coughs</span> become more productive and less frequent.<br>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>Indications And Usage:</h1>for temporary relief of non-<span class="product-label-link" type="condition" conceptid="4102774" conceptname="Productive cough">productive cough</span> accompanying <span class="product-label-link" type="condition" conceptid="4170108" conceptname="Respiratory tract congestion">respiratory tract congestion</span> associated with <br>the <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">common cold</span>, <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span>, <span class="product-label-link" type="condition" conceptid="4283893" conceptname="Sinusitis">sinusitis</span>, and <span class="product-label-link" type="condition" conceptid="256451" conceptname="Bronchitis">bronchitis</span>.<br>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>Contraindications:</h1>POLY HIST CB is contraindicated in infants and newborns, and in patients with a known <br><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the components. It is also contraindicated in patients on MAO inhibitor therapy.<br>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>Warnings:</h1>A persistent <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span> may be a sign of a serious condition. If <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span> persists for more than one week <br>or tends to recur, or is accompanied by <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, or persistent <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, patient reevaluation <br>should be considered.<br>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>Precautions:</h1>DRUG INTERACTIONS: Guaifenesin may produce an increase in urinary 5-hydroxy-indoleacetic acid and <br>may therefore interfere with the interpretation of this test for the diagnosis of <span class="product-label-link" type="condition" conceptid="199771" conceptname="Carcinoid syndrome">carcinoid syndrome</span>. It may <br>also falsely elevate the VMA test for catechols. Administration of this drug should be discontinued 48 hours <br>prior to the collection of urine specimens for such tests.<br>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-7"></a><p></p>
<h1>Carcinogenesis, Mutagenesis, And Impairment of Fertility:</h1>No adequate and well controlled studies have been conducted to determine whether the components <br>of POLY HIST CB have a potential for carcinogenesis, mutagenesis, or impairment of fertility.<br>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-8"></a><p></p>
<h1>Pregnancy:</h1>Pregnancy Category C: Animal reproduction studies have not yet been conducted with this product. <br>It is not known whether it can cause fetal harm when administered to a pregnant woman or can affect <br>reproduction capacity. This product should not be administered to pregnant women.<br>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-9"></a><p></p>
<h1>Nursing Mothers:</h1>Due to the possible passage of the ingredients into breast milk, this product should not be given to nursing mothers.<br>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-10"></a><p></p>
<h1>Adverse Reactions:</h1>Guaifenesin is well tolerated and has a wide margin of safety. Side effects are generally <br>mild and infrequent. <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> are the most common side effects. <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span>, <br><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, and <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> (including <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>) have been reported rarely.<br>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-11"></a><p></p>
<h1>Overdosage:</h1>SIGNS AND SYMPTOMS: Incidence of acute toxicity with guaifenesin is low and over dosage <br>is unlikely to produce serious toxic effects. In laboratory animals no toxicity resulted when <br>guaifenesin was administered by stomach tube in doses up to 5 grams/kg.<br><br><span class="Bold">TREATMENT:</span> Treatment of the signs and symptoms of overdosage is symptomatic and <br>supportive. The patient should be induced to vomit, even if <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> has occurred spontaneously. <br>Pharmacologic <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> by the administration of ipecac syrup is a preferred method, however, <br><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> should not be induced in patients with impaired consciousness. Precautions against <br><span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span> must be taken, especially in infants and children. Following <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span>, any drug <br>remaining in the stomach may be absorbed by activated charcoal administered as a slurry with water.<br>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-12"></a><p></p>
<h1>Dosage and Administration:</h1>POLY HIST CB is administered orally as follows:<br><br><span class="Bold">Adults:</span> 1-2 teaspoonfuls every 4-6 hours or as directed by a physician.<br><span class="Bold">Children 6-12 years of age: </span>1 teaspoonful every 4-6 hours or as directed by a physician.<br><span class="Bold">Children 2-6 years of age:</span> 1/2 teaspoonful every 4-6 hours or as directed by a physician.<br><span class="Bold">Children under 2 years of age:</span> As directed by a physician.<br><br><br>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-13"></a><p></p>
<h1>How Supplied:</h1>16 fluid ounce bottles NDC # 50991-781-16 and 15 mL bottles NDC # 50991-781-15<br><br><span class="Bold">KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.</span><br><span class="Bold">IN CASE OF ACCIDENTAL OVERDOSAGE, CONTACT A POISON CONTROL </span><br><span class="Bold">CENTER AND SEEK PROFESSIONAL ASSISTANCE IMMEDIATELY.</span><br><br>Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.<br><br>Store at controlled room temperature, 59<span class="Sup">o</span>-86<span class="Sup">o</span>F (15<span class="Sup">o</span>-30<span class="Sup">o</span>C).<br><br>DISPENSE IN TIGHT, LIGHT RESISTANT CONTAINERS WITH CHILD RESISTANT CLOSURES <br>AS DEFINED IN THE USP/NF.<br><br>Manufactured for:<br>Poly Pharmaceuticals<br>Mobile, AL 36619<br><br>Rx Only<br><br>Rev. 11/09<br>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-14"></a><p></p>
<h1>PRODUCT PACKAGING:</h1>The packaging below represents the labeling currently used:<br><br><span class="Bold">NDC 50991-781-16</span><br><br><span class="Bold">Poly Hist CB<br><br></span><span class="Bold">Grape Flavor</span><br><span class="Bold"><br>Sugar Freee      Alcohol Free</span><br><span class="Bold"><br>Antitussive/Expectorant</span><br><span class="Bold"><br>Each 5 mL (1 teaspoonful) contains:</span><br><span class="Bold">Carbetapentane Citrate..... 20 mg</span><br><span class="Bold">Guaifenesin...................... 75 mg</span><br><span class="Bold"><br><br>Distributed by:</span><br><span class="Bold"><span class="Bold">Poly Pharmaceuticals</span><br>Mobile, AL 36619</span><br><span class="Bold"><br>Rx Only</span><br><span class="Bold"><br>16 fl oz (473 mL)</span><br><span class="Bold"></span><br><br>Side Panel:<br><br><span class="Bold">USUAL DOSAGE:</span><span class="Bold"> Adults 12 years and older:</span> 1-2 teaspoonfuls every 4-6 hours.<br><span class="Bold">Children 6-12 years of age: </span>1 teaspoonful every 4-6 hours.<span class="Bold"> Children 2-6 years of age:</span><br>1/2 teaspoonful every 4-6 hours.<span class="Bold"> Children under 2 years of age:</span> As directed by a physician.<br><br>See package insert for complete prescribing information.<br><br><span class="Bold"></span><span class="Bold">KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. </span><br><span class="Bold">IN CASE OF ACCIDENTAL OVERDOSAGE, CONTACT A POISON CONTROL </span><br><span class="Bold">CENTER AND SEEK PROFESSIONAL ASSISTANCE IMMEDIATELY.</span><br><br>Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.<br><br>This bottle is not to be dispensed to consumer.<br><span class="Bold"><br>STORAGE: </span>Store at controlled room temperature, 59<span class="Sup">o</span>-86<span class="Sup">o</span>F (15<span class="Sup">o</span>-30<span class="Sup">o</span>C).<br><span class="Bold"><br>Mfg. for:</span> Poly Pharmaceuticals, Mobile, AL 36619<br><br><span class="Bold">Mfg. by:</span> Great Southern Laboratories. Houston, TX 77099<br><br>Rev. 11/09<br><br><span class="Bold"></span><div class="Figure"><img alt="Poly Hist CB Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c3a1a47a-27ce-4565-9d6a-a2d8314357a6&amp;name=MM1.jpg"></div>
<br><div class="Figure"><img alt="Poly Hist CB Packaging" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c3a1a47a-27ce-4565-9d6a-a2d8314357a6&amp;name=MM2.jpg"></div>
<br>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POLY HIST 		
					CB</strong><br><span class="contentTableReg">carbetapentane citrate, and guaifenesin liquid</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:50991-781</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Carbetapentane Citrate</strong> (Carbetapentane) </td>
<td class="formItem">Carbetapentane Citrate</td>
<td class="formItem">20 mg  in 5 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Guaifenesin</strong> (Guaifenesin) </td>
<td class="formItem">Guaifenesin</td>
<td class="formItem">75 mg  in 5 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">    </td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">GRAPE</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:50991-781-16</td>
<td class="formItem">473 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">11/30/2009</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Poly Pharmaceuticals, Inc.
							(198449894)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Great Southern Laboratories (056139553)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Great Southern Laboratories</td>
<td class="formItem"></td>
<td class="formItem">056139553</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 12/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>582a7a13-fdb4-4e80-8387-a34b140627ef</div>
<div>Set id: c3a1a47a-27ce-4565-9d6a-a2d8314357a6</div>
<div>Version: 1</div>
<div>Effective Time: 20091207</div>
</div>
</div> <div class="DistributorName">Poly Pharmaceuticals, Inc.</div></p>
</body></html>
